5 Hot Biotechs to Hold Over The Weekend
My Post-FDA Over-The-Weekend Watchlist:
GLYC
ONCT
ONCY
PIRS
AGEN
All of these biotechs have phase one cancer treatment clinical-trial data releases this weekend. Based on my research, these are the ones that I think are most likely to release good data. Since they are all in phase one, it is likely that we see a gap up on Monday and a solid downtrend from there. Like and follow for more biotech ideas like this :) Happy Trading!
[I]Remember that these are biotech stocks and there are no guarantees in this sector. Proceed with caution![/I]
GLYCONCTONCYPIRSAGENAll of these biotechs have phase one cancer treatment clinical-trial data releases this weekend. Based on my research, these are the ones that I think are most likely to release good data. Since they are all in phase one, it is likely that we see a gap up on Monday and a solid downtrend from there. Like and follow for more biotech ideas like this :) Happy Trading!
[I]Remember that these are biotech stocks and there are no guarantees in this sector. Proceed with caution![/I]
Publikasi terkait
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.